Apatinib in treating patients with platinum-resistant or platinum-refractory recurrent or metastatic nasopharyngeal carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz252.037
Abstract: Abstract Background To evaluate the efficacy and safety of apatinib in treating patients with platinum-resistant or platinum-refractory recurrent or metastatic nasopharyngeal carcinoma. Methods In this phase 2, single-arm, prospective study, we recruited patients aged 18–65… read more here.
Keywords: recurrent metastatic; platinum; resistant platinum; platinum refractory ... See more keywords
CTNI-64. PHASE 2 STUDY OF REGORAFENIB IN BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA
Sign Up to like & getrecommendations! Published in 2025 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noaf201.0560
Abstract: This phase 2 non-randomized prospective study was conducted to evaluate the efficacy and safety of regorafenib monotherapy in bevacizumab-refractory recurrent glioblastoma (GBM). Patients were enrolled based on documented radiographic progression of histologically confirmed GBM following… read more here.
Keywords: oncology; bevacizumab refractory; refractory recurrent; study ... See more keywords
CD56–chimeric antigen receptor T-cell therapy for refractory/recurrent rhabdomyosarcoma
Sign Up to like & getrecommendations! Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000017572
Abstract: Abstract Rationale: Rhabdomyosarcoma (RMS) is a common soft tissue sarcoma in children with high malignancy. The prognosis of refractory recurrent RMS is extremely poor, and the 5-year survival rate is less than 20%. Patient concerns:… read more here.
Keywords: therapy; rhabdomyosarcoma; cell; refractory recurrent ... See more keywords
Apatinib in treating patients with platinum-resistant or platinum-refractory recurrent or metastatic nasopharyngeal carcinoma.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e17502
Abstract: e17502 Background: To evaluate the efficacy and safety of apatinib in treating patients with platinum-resistant or platinum-refractory recurrent or metastatic nasopharyngeal carcinoma. Methods: In this phase 2, single-arm, prospective study, we recruited patients aged 18–65… read more here.
Keywords: platinum refractory; platinum resistant; refractory recurrent; platinum ... See more keywords
Eribulin and irinotecan for refractory or recurrent Ewing sarcoma: A retrospective study.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.e23502
Abstract: e23502 Background: The effectiveness of eribulin and irinotecan in treatment of xenograft models of Ewing sarcoma is well-established but little clinical data has been reported. Encouraging results from preclinical models and a shortage of temozolomide… read more here.
Keywords: eribulin irinotecan; recurrent ewing; ewing sarcoma; portion ... See more keywords
Candida isolates causing refractory or recurrent oropharyngeal candidiasis in 11 hospitals in China
Sign Up to like & getrecommendations! Published in 2019 at "Infection and Drug Resistance"
DOI: 10.2147/idr.s199359
Abstract: Introduction: We studied the species distribution and antifungal susceptibilities of Candida isolates causing refractory or recurrent oropharyngeal candidiasis (OPC) in a multicenter study in China (2013–2016). Methods: Species identification was performed using the Bruker Biotyper… read more here.
Keywords: recurrent oropharyngeal; candida isolates; causing refractory; refractory recurrent ... See more keywords
A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cellular and Infection Microbiology"
DOI: 10.3389/fcimb.2022.862526
Abstract: Objective We aimed to establish a model that can predict refractory/recurrent cytomegalovirus (CMV) infection after haploidentical donor (HID) hematopoietic stem cell transplantation (HSCT). Methods Consecutive acute leukemia patients receiving HID HSCT were enrolled (n =… read more here.
Keywords: cell; refractory recurrent; model; infection ... See more keywords
The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid Tumors
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.711704
Abstract: Objective: Refractory or recurrent pediatric solid tumors lack effective treatments, and are associated with dismal outcomes. Hence, there is an urgent need for a novel therapeutic strategy. This study aimed to evaluate the efficacy and… read more here.
Keywords: refractory recurrent; safety anlotinib; solid tumors; efficacy safety ... See more keywords
The Role of Antimicrobial Resistance in Refractory and Recurrent Bacterial Vaginosis and Current Recommendations for Treatment
Sign Up to like & getrecommendations! Published in 2022 at "Antibiotics"
DOI: 10.3390/antibiotics11040500
Abstract: Bacterial vaginosis (BV), the most common cause of vaginal discharge, is characterized by a shift in the vaginal microbiota from Lactobacillus species dominance to a diverse array of facultative and strict anaerobic bacteria which form… read more here.
Keywords: current recommendations; recommendations treatment; refractory recurrent; antimicrobial resistance ... See more keywords